Extended Follow Up of the Mainritsan 2 Study. Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab: a Placebo- Controlled Randomized Trial

Trial Profile

Extended Follow Up of the Mainritsan 2 Study. Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab: a Placebo- Controlled Randomized Trial

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Rituximab (Primary)
  • Indications Microscopic polyangiitis; Wegener's granulomatosis
  • Focus Therapeutic Use
  • Acronyms MAINRITSAN3
  • Most Recent Events

    • 14 Sep 2016 Status changed from recruiting to active, no longer recruiting.
    • 07 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top